A Metabolite of the Lupus-Inducing Drug Procainamide Prevents Anergy Induction in T Cell Clones

Journal of Immunology

Volumn 158, Issue 9, 1997, Pages 4465-4470

  Kretz Rommel, Anke ^a   Rubin, Robert L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCAINAMIDE;

A J MOUSE; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CLONAL ANERGY; DRUG EFFECT; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TIME;

ANIMALS; CLONAL ANERGY; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED A; PROCAINAMIDE; T-LYMPHOCYTES; TH1 CELLS; TIME FACTORS;

EID: 0031135289     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Hess, E. V., and A.-B. Mongey. 1993. Dmg-related lupus: the same as or different from idiopathic disease? In Systemic Lupus Erythematosus. R. G. Lahita, ed. Churchill Livingstone, New York, pp. 893-904.
2. Yung, R. L., and B. C. Richardson. 1994. Drug-induced lupus. Rheum. Dis. Clin. North Am. 20:61.
3. Rubin, R. L. 1996. Drug-induced lupus. In Dubois' Lupus Erythematosus, 5th Ed. D. J. Wallace and B. H. Hahn, eds. Williams & Wilkins, Baltimore, MD, pp. 871-901.
4. Woosley, R. L., D. E. Drayer, M. M. Reidenberg, A. S. Nies, K. Carr, and J. A. Oates. 1978. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N. Engl. J. Med. 298: 1157.
5. Rubin, R. L. 1989. Autoimmune reactions induced by procainamide and hydralazine. In Autoimmunity and Toxicology: Immune Disregulation Induced by Drugs and Chemicals. M. Kammuller, M. Bloksma, and W. Seimen, eds. Elsevier, Amsterdam, pp. 119-150.
6. Cornacchia, E., J. Golbus, J. Maybaum, J. Strahler, S. Hanash, and B. Richardson. 1988. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140:2197.
7. Yung, R. L., J. Quddus, C. E. Chrisp, K. J. Johnson, and B. C. Richardson. 1995. Mechanisms of drug-induced lupus, I: cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154: 3025.
8. Rubin, R. L. 1994. Role of xenobiotic oxidative metabolism. Lupus 3:479.
9. Rubin, R. L., and J. T. Curnutte. 1989. Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro. J. Clin. Invest. 83:1336.
10. Uetrecht, J. 1989. Mechanism of hypersensitivity reactions: proposed involvement of reactive metabolites generated by activated leukocytes. Trends Pharmacol. Sci. 10:463.
11. Jiang, X., G. Khursigara, and R. L. Rubin. 1994. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 266:810.
12. Hill, C. M., J. Lunec, H. R. Griffiths, and K. E. Herbert. 1995. Characterization of tumour necrosis factor a release by human granulocytes in response to procainamide challenge. Biochem. Pharmacol. 49:1837.
13. Kubicka-Muranyi, M., R. Goebels, C. Goebel, J. Uetrecht, and E. Gleichmann. 1993. T lymphocytes ignore procainamide but respond to its reactive metabolites in peritoneal cells: demonstration by the adoptive transfer popliteal lymph node assay. Toxicol. Appl. Pharmacol. 122:88.
14. Adams, L. E., K. Balakrishnan, S. M. Roberts, R. Belcher, A. Mongey, T. J. Thomas, and E. V. Hess. 1993. Genetic, immunologic and biotransformation studies of patients on procainamide. Lupus 2:89.
15. Uetrecht, J. P. 1985. Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide. J. Pharmacol. Exp. Ther. 232:420.
16. Roberts, S. M., L. E. Adams, R. Donovan-Brand, R. Budinsky, N. P. Skoulis, H. Zimmer, and E. V. Hess. 1989. Procainamide hydroxylamine lymphocyte toxicity-1: evidence for participation by hemoglobin. Int. J. Immunopharmacol. 11:419.
17. Adams, L. E., S. M. Roberts, J. M. Carter, J. F. Wheeler, H. W. Zimmer, R. J. Donovan-Brand, and E. V. Hess. 1990. Effects of procainamide hydroxylamine on generation of reactive oxygen species by macrophages and production of cytokines. Int. J. Immunopharmacol. 12:809.
18. Adams, L. E., C. E. Sanders, Jr., R. A. Budinsky, R. Donovan-Brand, S. M. Roberts, and E. V. Hess. 1989. Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupus. J. Lab. Clin. Med. 113:482.
19. Rubin, R. L., J. P. Uetrecht, and J. E. Jones. 1987. Cytotoxicity of oxidative metabolites of procainamide. J. Pharmacol. Exp. Ther. 242:833.
20. Wheeler, J. F., C. E. Lunte, W. R. Heineman, L. Adams, and E. V. Hess. 1988. Rapid communications: electrochemical determination of N-oxidized procainamide metabolites and functional assessment of effects on murine cells in vitro. Proc. Soc. Exp. Biol. Med. 188:381.
21. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
22. Weaver, C. T., C. M. Hawrylowicz, and E. R. Unanue. 1988. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. USA 85:8181.
23. Williams, M. E., C. M. Shea, A. H. Lichtman, and A. K. Abbas. 1992. Antigen receptor-mediated anergy in resting T lymphocytes and T cell clones: correlation with lymphokine secretion patterns. J. Immunol. 149:1921.
24. Jayaraman, S., Y. Luo, and M. E. Dorf. 1992. Tolerance induction in T helper (Th1) cells by thymic macrophages. J. Immunol. 148:2672.
25. Gilbert, K. M., K. D. Hoang, and W. O. Weigle. 1990. Th1 and Th2 clones differ in their response to a tolerogenic signal. J. Immunol. 144:2063.
26. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195.
27. Friccius, H., P. Siegels-Hübenthal, A. Rehbein, E. Schlotz, and G. Pawelec. 1993. Induction of hyporesponsiveness in human lymphocytes-T despite their expression of both the co-receptor CD28 and its ligand B7. Cell. Immunol. 151:283.
28. Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587.
29. Johnson, J. G., and K. M. Jenkins. 1994. The role of anergy in peripheral T cell unresponsiveness. Life Sci. 55:1767.
30. Ramsdell, F., and B. J. Fowlkes. 1990. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 248:1342.
31. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
32. Uetrecht, J. P., B. J. Sweetman, R. L. Woosley, and J. A. Oates. 1984. Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes. Drug Metab. Dispos. 12:77.
33. Ashwell, J. D., C. Chen, and R. H. Schwartz. 1986. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J. Immunol. 136:389.
34. Self, C. H. 1985. Enzyme amplification-a general method applied to provide an immunoassisted assay for placental alkaline phosphatase. J. Immunol. Methods 76:389.
35. Beverly, B., S. Kang, M. J. Lenardo, and R. H. Schwartz. 1991. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4:661.
36. Jenkins, M. K., C. Chen, G. Jung, D. L. Mueller, and R. H. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144: 16.
37. Wheeler, J. F., L. E. Adams, A.-B. Mongey, S. M. Roberts, W. R. Heineman, and E. V. Hess. 1991. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection. Drug Metab. Dispos. 19:691.
38. Quill, H., M. P. Riley, E. A. Cho, J. E. Casnellie, J. C. Reed, and T. Torigoe. 1992. Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J. Immunol. 149:2887.
39. Cho, E. A., M. P. Riley, A. L. Sillman, and H. Quill. 1993. Altered protein tyrosine phosphorylation in anergic Th1 cells. J. Immunol. 151:20.
40. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signalling: altered phospho-ζ and lack of ZAP70 recruitment in APL-induced T cell anergy. Cell 79:913.
41. Jenkins, M. K., D. M. Pardoll, J. Mizuguchi, T. M. Chused, and R. H. Schwartz. 1987. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 84:5409.
42. 2+ and tyrosine signaling pathways. Proc. Natl. Acad. Sci. USA 91:38.
43. Go, C., and J. Miller. 1992. Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation. J. Exp. Med. 175:1327.
44. Wotton, D., J. A. Higgins, R. E. O'Hehir, J. R. Lamb, and R. A. Lake. 1995. Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy. Hum. Immunol. 42:95.
45. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263.
46. Quill, H., and R. H. Schwartz. 1987. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J. Immunol. 138:3704.
47. Nakashima, I., M. Pu, A. Nishizaki, I. Rosila, L. Ma, Y. Katano, K. Ohkusu, S. M. J. Rahman, K. Isobe, M. Hamaguchi, and K. Saga. 1994. Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals. J. Immunol. 152:1064.
48. Buttke, T. M., and P. A. Sandstrom. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7.
49. L and Bcl-2, displaces Bax and promotes cell death. Cell 80:285.
50. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J. Vayssière, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661.
51. + T cells. Science 271:1276.
52. Dayal, A. K., and G. M. Kammer. 1996. The T cell enigma in lupus. Arthritis Rheum. 39:23.
53. Ashton-Rickardt, P. G., and S. Tonegawa. 1994. A differential-avidity model for T-cell selection. Immunol. Today 15:362.
54. Bevan, M. J., K. A. Hogquist, and S. C. Jameson. 1994. Selecting the T cell receptor repertoire. Science 264:796.
55. Kawai, K., and P. S. Ohashi. 1995. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Nature 374:68.
56. Ramsdell, F., T. Lantz, and B. J. Fowlkes. 1989. A. nondeletional mechanism of thymic self tolerance. Science 246:1038.
57. Roberts, J. L., S. O. Sharrow, and A. Singer. 1990. Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J. Exp. Med. 171:935.
58. Budinsky, R. A., S. M. Roberts, E. A. Coates, L. Adams, and E. V. Hess. 1987. The formation of hydroxylamine by rat and human liver microsomes. Drug Metab. Disp. 15:37.
59. Kretz-Rommel, A., S. R. Duncan, and R. L. Rubin. 1997. Autoimmunity caused by disruption of central T cell tolerance: a murine model of drug-induced lupus. J. Clin. Invest. In press.